AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$865M
1-Year Est. Return
95.13%
This Fund
S&P 500
1 Year Est. Return
+95.13%
AUM
$865M
AUM Growth
+$113M
(+15%)
Holding
9
Top Buys
No buys this quarter
Top Sells
| 1 | +$53.1M | |
| 2 | +$23.5M | |
| 3 | +$16M | |
| 4 |
IMA
ImageneBio Inc
IMA
|
+$3.08M |
| 5 |
Day One Biopharmaceuticals
DAWN
|
+$148K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$7.21B
| $363M | 41.91% |
4,659,874
-236,588
|
|
||
2
Dyne Therapeutics
DYN
$2.66B
| $179M | 20.64% |
9,130,465
|
|
||
|
SION
3
Sionna Therapeutics
SION
$1.51B
| $123M | 14.24% |
2,995,602
-619,925
|
|
||
4
Disc Medicine
IRON
$2.51B
| $120M | 13.9% |
1,513,875
-628,742
|
|
||
|
5
Day One Biopharmaceuticals
DAWN
$1.06B
| $59.8M | 6.91% |
6,412,560
-17,697
|
|
||
6
Korro Bio
KRRO
$108M
| $9.11M | 1.05% |
1,137,149
|
|
||
7
Q32 Bio
QTTB
$60.9M
| $6.95M | 0.8% |
2,092,106
|
|
||
|
GBIO
8
DELISTED
Generation Bio
GBIO
| $4.7M | 0.54% |
827,946
|
|
||
|
IMA
9
ImageneBio Inc
IMA
$71.2M
| – | – |
-377,814
|
|